Skip to main content

Table 2 Characteristics of AML patients with a wild type or mutated IDH1

From: Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients

Variable

All cases

IDH1 m

IDH1 wt

P*

No. of cases

230

20

210

 

No. of males/females

101/129

5/15

96/114

.058

Age, years

   

.860†

   Median (range)

44 (13-86)

42.5 (15-85)

45 (13-86)

 

Hemoglobin, g/dL

   

.311†

   Median (range)

7.8 (1.4 -14.5)

7.4 (2.9 - 10.8)

7.85(1.4-14.5)

 

WBC count, x10 9 /L

   

.323†

   Median (range)

27.7 (0.6 -494.4)

26.9 (1.0 -190.9)

27.7 (0.6 -494.4)

 

Platelet, x10 9 /L

   

.923†

   Median (range)

46 (1.8-965)

56 (16.9 - 386)

45.5 (1.8-965)

 

Percentage of blasts

   

.738†

   Median (range)

70.19 (6.69-95.44)

75.8 (13.3-91.4)

69.77 (6.69-95.44)

 
  

Patients (%)

Patients (%)

 

FAB classification

    

   M0

3

1 (5)

2 (0.9)

 

   M1

51

1 (5)

50 (23.8)

 

   M2

76

13 (65)

63 (30)

 

   M3

36

5 (25)

31 (15)

 

   M4

34

0 (0)

34 (16)

 

   M5

21

0 (0)

21 (10)

 

   M6

8

0 (0)

8 (3.8)

 

   M7

1

0 (0)

1 (0.5)

 
  

Patients (%)

Patients (%)

 

Cytogenetics

    

   Abnormal

    

   t(15;17)

36

5 (25)

31 (15)

.184

   t(8;21)

20

0 (0)

20 (10)

.149

   inv(16)

3

0 (0)

3 (1)

.760

   trisomy 8

4

1 (5)

3 (1)

.307

   Other trisomies

7

0 (0)

7 (3)

.524

   All others including monosomies, deletions or combination of these

22

2 (10)

20 (10)

.594

   Complex karyotype

8

0 (0)

8 (4)

.477

   Normal

126

11 (55)

115 (55)

.587

  1. Abbreviation: IDH1m, IDH1 mutated; IDH1wt, IDH1 wild type
  2. * Fisher exact test unless otherwise indicated; †, the student t- test